Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03171220
What this trial is testing

Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Testing effectiveness (Phase 2)UnknownNCT04588324
What this trial is testing

Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Chinese PLA General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT05134948
What this trial is testing

Assess Relatlimab and Nivolumab Fixed-dose Combination in Chinese Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 24
Large-scale testing (Phase 3)UnknownNCT03700476
What this trial is testing

Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 425
Not applicableStudy completedNCT05942768
What this trial is testing

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Adenocarcinoma
Hunan Cancer Hospital 103
Testing effectiveness (Phase 2)Study completedNCT03092895
What this trial is testing

SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

Who this might be right for
Advanced Primary Liver CancerAdvanced Biliary Tract Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 157
Early research (Phase 1)Study completedNCT04635995
What this trial is testing

Phase 1 Trial of LVGN7409 (CD40 Agonist Antibody) as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy

Who this might be right for
Cancer
Lyvgen Biopharma Holdings Limited 66
Testing effectiveness (Phase 2)Looking for participantsNCT06529718
What this trial is testing

Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

Who this might be right for
Biliary Tract Cancer
UNICANCER 72
Testing effectiveness (Phase 2)Ended earlyNCT04812535
What this trial is testing

Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.

Who this might be right for
SCC - Squamous Cell Carcinoma of Skin
InflaRx GmbH 30
Large-scale testing (Phase 3)Study completedNCT03088540
What this trial is testing

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma，Non-Small-Cell LungLung Carcinomas, Non-Small-CellNon-small-cell Lung Carcinoma+1 more
Regeneron Pharmaceuticals 712
Not applicableNot Yet RecruitingNCT07809165
What this trial is testing

Sequential PD-1 Antibody and Pegylated Interferon Therapy for Nucleos(t)Ide Analogue-suppressed Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Beijing 302 Hospital 60
Not applicableUnknownNCT05638438
What this trial is testing

Efficacy and Safety of Transarterial Therapies+Donafenib + Anti-PD-1 Antibody for uHCC: A Retrospective Real-world Study

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Zhujiang Hospital 100
Testing effectiveness (Phase 2)UnknownNCT04413734
What this trial is testing

Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma by AJCC V8 Stage
Zhejiang University 120
Testing effectiveness (Phase 2)Ended earlyNCT02880371
What this trial is testing

ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pfizer 82
Large-scale testing (Phase 3)Study completedNCT03866993
What this trial is testing

Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer Non-small Cell Stage IVSquamous Cell Lung Cancer
Akeso 350
Testing effectiveness (Phase 2)Looking for participantsNCT06002789
What this trial is testing

Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC

Who this might be right for
Multiple CancerColorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 17
Not applicableUnknownNCT04970043
What this trial is testing

Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC Treatment

Who this might be right for
Lung Cancer Stage II
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 58
Testing effectiveness (Phase 2)Looking for participantsNCT05882370
What this trial is testing

TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study

Who this might be right for
Hepatocellular Carcinoma
Fei Gao 30
Testing effectiveness (Phase 2)Study completedNCT03304639
What this trial is testing

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

Who this might be right for
Advanced Merkel Cell CarcinomaClinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8+5 more
National Cancer Institute (NCI) 9
Not applicableLooking for participantsNCT06417892
What this trial is testing

Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma

Who this might be right for
Gastric Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Next Page